1971 A correlative study of Ki67 and two multigene RNA expression signatures in operable ER-positive postmenopausal breast cancer (SAKK 26/10) von Jaggi, R, Varga, Z, Bigler, M, Bize, V, Bustamante Eduardo, M, Berardi, S, Chiesa, F, Dedes, K.J, Müller, A, Tausch, C, Vetter, M, Von Moos, R, Winterhalder, R.C, Zimmermann, S, Pestalozzi, B, Aebi, S

Volltext

1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10) von Pestalozzi, B.C, Tausch, C, Dedes, K.J, Rochlitz, C, Zimmermann, S, Von Moos, R, Winterhalder, R.C, Ruhstaller, T, Mueller, A, Buser, K.S, Borner, M.M, Novak, U, Uhlmann Nussbaum, C, Seifert, B, Bigler, M, Bize, V, Berardi Vilei, S, Rageth, C, Aebi, S.P

Volltext

1145P Reliable detection of BRCA1 and BRCA2 large genomic rearrangements in FFPE tissue: A new diagnostic benchmark for somatic BRCA testing von Valtcheva, N., Nguyen, B.D., Wagner, U., Freiberger, S., Varga, Z., Britschgi, C., Dedes, K.J., Rechsteiner, M.

Volltext

A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland von Panje, C.M., Lupatsch, J.E., Barbier, M., Pardo, E., Lorez, M., Dedes, K.J., Aebersold, D.M., Plasswilm, L., Gautschi, O., Schwenkglenks, M.

Volltext

PO-1013: A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC von Panje, C., Lupatsch, J.E., Barbier, M., Pardo, E., Lorez, M., Dedes, K.J., Aebersold, D.M., Plasswilm, L., Gautschi, O., Schwenkglenks, M.

Volltext

1790P Single-cell ex vivo drug response testing platform on fluid samples from patients with solid tumors von Bankel, L., Wegmann, R., Dedes, K.J., Franzen, D., Bode, P.K., Zoche, M., Arnold, F., Moch, H., Manz, M.G., Britschgi, C., Snijder, B.

Volltext

Cost-effectiveness of nivolumab in the treatment of head and neck cancer von Hirschmann, A., Lupatsch, J.E., Schwenkglenks, M., Panje, C.M., Matter-Walstra, K., Espeli, V., Dedes, K.J., Siano, M.

Volltext

1834P Impact of comprehensive genomic profiling and molecular tumor board decision on clinical outcome of patients with solid tumors: A single center, retrospective analysis von Ludwig, S.V., Schmid, L., Kahraman, A., Rechsteiner, M., Zoche, M., Curioni-Fontecedro, A., Siebenhüner, A.R., Dedes, K.J., Kiessling, M., Fritsch, R., Wicki, A., Moch, H., Weber, A., Britschgi, C.

Volltext

268P Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple-negative, EGFR positive breast cancer: A multicenter single arm phase II trial [SAKK 24/14] von Wicki, A., Mamot, C., Hasler-Strub, U., Riniker, S., Li, Q., Holer, L., Baertschi, D., Zaman, K., von Moos, R., Dedes, K.J., Novak, U., Bodmer, A., Ritschard, R., Obermann, E., Ackermann, C.J., Membrez-Antonioli, V., Zuerrer, U., Caspar, C.B., Rochlitz, C., Winterhalder, R.C.

Volltext

Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial von Dedes, KJ, Szucs, TD, Imesch, P, Fedier, A, Fehr, MK, Fink, D

Volltext

Trastuzumab beyond progression: a cost-utility analysis von Matter-Walstra, K.W., Dedes, K.J., Schwenkglenks, M., Brauchli, P., Szucs, T.D., Pestalozzi, B.C.

Volltext

Balancing costs and benefits in cancer therapy and prevention von Szucs, T. D., Dedes, K. J.

Volltext

Cost-effectiveness studies in ovarian cancer von Szucs, T.D., Wyss, P., Dedes, K.J.

Volltext